Page last updated: 2024-09-03

salmfamide 2 and 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one

salmfamide 2 has been researched along with 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one in 1 studies

*1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one: structure given in first source; inhibits guanylyl cyclase [MeSH]

*1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one: structure given in first source; inhibits guanylyl cyclase [MeSH]

Compound Research Comparison

Studies
(salmfamide 2)
Trials
(salmfamide 2)
Recent Studies (post-2010)
(salmfamide 2)
Studies
(1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one)
Trials
(1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one)
Recent Studies (post-2010) (1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one)
11047930110

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elphick, MR; Melarange, R1

Other Studies

1 other study(ies) available for salmfamide 2 and 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one

ArticleYear
Comparative analysis of nitric oxide and SALMFamide neuropeptides as general muscle relaxants in starfish.
    The Journal of experimental biology, 2003, Volume: 206, Issue:Pt 5

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Cyclic AMP; Cyclic GMP; Muscle Relaxation; Neuropeptides; Nitric Oxide; Oxadiazoles; Quinoxalines; Radioimmunoassay; Starfish; Stomach

2003